Usually competition is the name of the game, but 3 major pharma companies are combining forces in a For Profit venture to work on research projects in what appears to be a collective manner to speed up the R and D processes. BD
Merck, Lilly and Pfizer are teaming with PureTech Ventures, a venture capital firm, to create a new entity that will focus on drug-discovery methods in hopes of reducing the failure rate of clinical trials, The Wall Street Journal reports. The new firm will be called Enlight Biosciences and has $39 million in backing.
0 comments :
Post a Comment